Portfolio of Synthetic Biology Stocks

Here is a table of 5 synthetic biology stocks.


5 Synthetic Biology Stocks

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

AmyrisAMRS
CodexisCDXS
GevoGEVO
IntrexonXON
ZIOPHARM OncologyZIOP
Price data from Quandl as of most recent close.


To inspect the performance of the Synthetic Biology Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 4 stocks included in the portfolio computations are: AMRS, CDXS, GEVO and ZIOP. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. XON was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $15,661. The percent return is 56.61%. The annualized return is 6.62%.




Return Summary for Synthetic Biology Stocks
Start DateOct-31-2012
Start Investment$10,000.00
End DateOct-17-2019
Current Value of Investment$15,661.41
Total Return56.61%
Annualized Return6.62%
Min DateAug-31-2016
Min Price$7,139.91
Max DateNov-30-2018
Max Price$23,174.12
# Values85
Number Returns3,570
Number Profitable Returns2,414
Percent Profitable Returns67.62%
Number Unprofitable Returns1,156
Percent Unprofitable Returns32.38%
Profitable to Unprofitable Returns Ratio2.09



NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.


Related Portfolios

Portfolio of Biofuel Stocks

Portfolio of Biotech Stocks

Portfolio of Genomics Stocks